PCSA (Processa Pharmaceuticals) FCF Margin %: 0.00% (As of Mar. 2026)

What is Processa Pharmaceuticals FCF Margin %?

Processa Pharmaceuticals PCSA +9.64% 28 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates PCSA with a GF Score™ of 28/100. The stock has 1 warning sign investors should review. Among 949 Biotechnology companies, Processa Pharmaceuticals ranks worse than 105373.97% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Processa Pharmaceuticals's Free Cash Flow for the three months ended in Mar. 2026 was $-3.59 Mil. Processa Pharmaceuticals's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Processa Pharmaceuticals's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Processa Pharmaceuticals's current FCF Yield % is -204.92%.

The historical rank and industry rank for Processa Pharmaceuticals's FCF Margin % or its related term are showing as below:

During the past 13 years, the highest FCF Margin % of Processa Pharmaceuticals was -860.00%. The lowest was -860.00%. And the median was -860.00%.

PCSA's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -82.65
* Ranked among companies with meaningful FCF Margin % only.

Processa Pharmaceuticals FCF Margin % Related Terms

Processa Pharmaceuticals FCF Margin % Historical Data

* Premium members only.

The historical data trend for Processa Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Processa Pharmaceuticals FCF Margin % Chart

Processa Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

FCF Margin %

Get a 7-Day Free Trial

0.00

Processa Pharmaceuticals Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
FCF Margin %	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

PCSA vs ELAB, MBIO, DRMA: FCF Margin % Comparison

For the Biotechnology subindustry, Processa Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Processa Pharmaceuticals FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Processa Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Processa Pharmaceuticals's FCF Margin % falls into.

Save Embed

28GF Score

Processa Pharmaceuticals Inc PCSA

FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Processa Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Processa Pharmaceuticals's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-12.235	/	0
	=	%

Processa Pharmaceuticals's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-3.591	/	0
	=	%

Frequently Asked Questions Learn more about FCF Margin % →

What does a FCF Margin % of 0.00% mean?

Processa Pharmaceuticals (PCSA) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Processa Pharmaceuticals and its competitors. According to the industry distribution chart, Processa Pharmaceuticals ranks #999999 out of 949 companies in the Biotechnology industry.

Is Processa Pharmaceuticals' FCF Margin % too high?

Processa Pharmaceuticals' current FCF Margin % is 0.00%. Based on the distribution chart, Processa Pharmaceuticals ranks #999999 out of 949 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Processa Pharmaceuticals has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.

How does Processa Pharmaceuticals' FCF Margin % compare to ELAB and MBIO?

According to the Biotechnology industry distribution chart, Processa Pharmaceuticals ranks #999999 out of 949 companies for FCF Margin %. This places Processa Pharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good FCF Margin % for a Biotechnology company?

A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high FCF Margin % mean?

A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Processa Pharmaceuticals and its competitors. Processa Pharmaceuticals's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Processa Pharmaceuticals stock overvalued right now?

Processa Pharmaceuticals (PCSA) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Processa Pharmaceuticals' overall GF Score™ is 28/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is FCF Margin % calculated?

FCF Margin % is calculated from a company's financial statements. For Processa Pharmaceuticals (PCSA), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Processa Pharmaceuticals Business Description

Industry Healthcare Biotechnology

Comparable Companies ELAB MBIO DRMA LIMN TCRT GNPX MLEC CLGN CPMV ADIL VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Address 601 21st Street, Suite 300, Vero Beach, FL, USA, 32960

Website https://www.processapharmaceuticals.com

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The four NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS11T, also referred to as NGC-Iri, is an analog of SN38, and PCS11T, PCS12852, and PCS499.

28GF Score

Get the complete analysis for PCSA

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.16

Price

View PCSA Analysis

See FCF Margin % data for all stocks →